Management strategies for post-transplant IgA nephropathy in kidney transplant recipients: a scoping review.

Rituxan (rituximab) - Roche

budesonide - Generic mfg.

Fabhalta (iptacopan) - Novartis

Tai'ai (telitacicept) - Vor Biopharma

http://www.ncbi.nlm.nih.gov/pubmed/42687161

Alexander P Maxwell; Gareth J McKay; Mark McClure; Michael Toal; Samuel Bell

Sep 4, 2026